Edgewood Management LLC Lowers Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Edgewood Management LLC lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.3% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,813,011 shares of the medical equipment provider’s stock after selling 220,953 shares during the period. Intuitive Surgical accounts for about 4.2% of Edgewood Management LLC’s holdings, making the stock its 13th largest holding. Edgewood Management LLC owned 0.79% of Intuitive Surgical worth $1,468,279,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Bennett Selby Investments LP grew its stake in shares of Intuitive Surgical by 3.9% in the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after acquiring an additional 17 shares during the last quarter. Onefund LLC boosted its stake in Intuitive Surgical by 1.9% in the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock worth $494,000 after purchasing an additional 18 shares in the last quarter. LVW Advisors LLC grew its position in Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after purchasing an additional 19 shares during the last quarter. Wesbanco Bank Inc. increased its stake in Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after purchasing an additional 19 shares in the last quarter. Finally, FSM Wealth Advisors LLC raised its holdings in Intuitive Surgical by 3.7% in the fourth quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock worth $275,000 after buying an additional 19 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Jamie Samath sold 269 shares of the company’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the transaction, the chief financial officer now directly owns 3,282 shares of the company’s stock, valued at $1,936,380. This represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock valued at $17,691,621 over the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Down 8.7 %

ISRG stock opened at $451.58 on Friday. The business’s 50-day moving average price is $545.18 and its 200-day moving average price is $532.64. The stock has a market cap of $160.84 billion, a P/E ratio of 70.45, a PEG ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Analysts Set New Price Targets

A number of research firms have recently commented on ISRG. Truist Financial cut their price target on shares of Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating on the stock in a report on Monday, March 17th. UBS Group lifted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a report on Monday, January 27th. CICC Research started coverage on Intuitive Surgical in a report on Monday, January 27th. They set a “neutral” rating and a $550.00 price target on the stock. Leerink Partners lifted their price objective on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Finally, Citigroup upped their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $611.86.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.